Date: February 5, 2025
Time: 8:00am PT, 11:00am ET
The advent of the spatial omics era has enabled researchers to acquire vast amounts of transcriptomics and proteomics data. The abundance of a transcript, however, does not necessarily display strong correlation with protein expression levels, so a holistic approach to sample analysis is crucial.
HCR™ Pro RNA-FISH by Molecular Instruments enables high-resolution, multiplex detection of transcripts without requiring harsh protease-digestion steps. The in situ proximity ligation assay technology from Navinci allows the study of protein functional states by sensitively detecting protein-protein interactions. Both technologies can be fully and robustly automated on the BOND RX automated research stainer by Leica Biosystems.
For the first time, we have combined two state-of-the art technologies for detecting RNA expression and protein interactions to better understand tissue phenotypes from a functional perspective. As a proof of principle, we focused on the PD1/PD-L1 inhibitory pathway, detecting the PD1 and PD-L1 transcripts, as well as the interaction between them on a protein level.
Learning Objectives
- Understand the HCR™ platform: Gain insights into the HCR™ Pro RNA-ISH assay, its automation capabilities on the BOND RX by Leica Biosystems, and the unique benefits it offers for clinical-grade workflows
- Describe what Navinci's isPLA technology is, how it can be automated on the BOND RX and how isPLA can be combined with HCR™ Pro RNA-FISH.
- Learn how the flexibility of the BOND RX enables automation of a wide range of technologies and helps researchers drive their discoveries forward.
Webinars will be available for unlimited on-demand viewing after live event.